Literature DB >> 31890683

Identification and performance of multiple clinical and laboratorial risk factors for diagnosis of cardiac autonomic neuropathy in type 1 diabetes patients.

Cinthia Minatel Riguetto1, Caroline Rigoleto Takano1, Sharon Nina Admoni2, Maria Candida Ribeiro Parisi1, Maria Lucia Correa Giannella2, Elizabeth João Pavin1, Arnaldo Moura Neto1.   

Abstract

PURPOSE: The incidence of cardiac autonomic neuropathy (CAN) in patients with type 1 diabetes (T1D) is frequently underestimated. Individuals with T1D and CAN have an increased mortality risk, mainly from cardiovascular causes. The objectives of the present study were to assess the clinical and laboratory characteristics associated with CAN in patients with T1D and verify the ability of multiple clinical factors to help identify patients with this condition.
METHODS: 102 patients with T1D were evaluated for CAN using standardized cardiovascular reflex testing. Clinical characteristics were used to compute a numerical score for CAN diagnosis and a ROC curve elaborated for assessment of the best cutoff to predict CAN. This score was then applied to the second sample of 120 patients. The sensitivity, specificity, and positive and negative predictive values were calculated.
RESULTS: Prevalence of CAN was around 35% in the first sample of patients and just below 20% in the second sample. Hypertension, total cholesterol, triglycerides, postprandial sweating, diastolic blood pressure, abnormal right and left 10 g monofilament, retinopathy, and nephropathy were considered independent predictors of CAN. The CAN-score cut-off was 16.88. This yielded a sensitivity of 50%, specificity 73.8%, positive predictive value 22.9%, and negative predictive value 90.5%.
CONCLUSION: The use of a subset of clinical and laboratory characteristics can be more accessible than the cardiac reflex tests and more accurate than a single isolated characteristic. © Springer Nature Switzerland AG 2019.

Entities:  

Keywords:  Cardiac autonomic neuropathy; Cardiovascular reflex test; Heart rate variability; Type 1 diabetes

Year:  2019        PMID: 31890683      PMCID: PMC6915171          DOI: 10.1007/s40200-019-00467-2

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  30 in total

1.  The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis.

Authors:  Raelene E Maser; Braxton D Mitchell; Aaron I Vinik; Roy Freeman
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

2.  Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

Authors:  S Tesfaye; L K Stevens; J M Stephenson; J H Fuller; M Plater; C Ionescu-Tirgoviste; A Nuber; G Pozza; J D Ward
Journal:  Diabetologia       Date:  1996-11       Impact factor: 10.122

3.  Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus.

Authors:  D R Witte; S Tesfaye; N Chaturvedi; S E M Eaton; P Kempler; J H Fuller
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

Review 4.  Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy.

Authors:  H Kaufmann
Journal:  Clin Auton Res       Date:  1996-04       Impact factor: 4.435

5.  Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management.

Authors:  Vincenza Spallone; Dan Ziegler; Roy Freeman; Luciano Bernardi; Simona Frontoni; Rodica Pop-Busui; Martin Stevens; Peter Kempler; Jannik Hilsted; Solomon Tesfaye; Phillip Low; Paul Valensi
Journal:  Diabetes Metab Res Rev       Date:  2011-10       Impact factor: 4.876

6.  Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group.

Authors:  D Ziegler; F A Gries; H Mühlen; W Rathmann; M Spüler; F Lessmann
Journal:  Diabete Metab       Date:  1993

Review 7.  Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.

Authors:  Victoria A Serhiyenko; Alexandr A Serhiyenko
Journal:  World J Diabetes       Date:  2018-01-15

8.  Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes.

Authors:  Catherine T Prince; Aaron M Secrest; Rachel H Mackey; Vincent C Arena; Lawrence A Kingsley; Trevor J Orchard
Journal:  Diabetes Care       Date:  2009-12-29       Impact factor: 17.152

9.  Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.

Authors:  Aaron I Vinik; Tomris Erbas; Carolina M Casellini
Journal:  J Diabetes Investig       Date:  2013-01-29       Impact factor: 4.232

10.  Association between impaired cardiovascular autonomic function and hypoglycemia in patients with type 1 diabetes.

Authors:  Mamta Jaiswal; Katherine McKeon; Nicholas Comment; James Henderson; Scott Swanson; Cynthia Plunkett; Patrick Nelson; Rodica Pop-Busui
Journal:  Diabetes Care       Date:  2014-06-27       Impact factor: 19.112

View more
  1 in total

Review 1.  The Potential of Current Noninvasive Wearable Technology for the Monitoring of Physiological Signals in the Management of Type 1 Diabetes: Literature Survey.

Authors:  Elena Daskalaki; Anne Parkinson; Nicola Brew-Sam; Md Zakir Hossain; David O'Neal; Christopher J Nolan; Hanna Suominen
Journal:  J Med Internet Res       Date:  2022-04-08       Impact factor: 7.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.